jCyte
Phase 3jCyte is pursuing multiple drug development programs for a range of degenerative retinal disorders and optic nerve conditions, focusing on preserving and restoring vision in patients.
Founded
2012
Focus
Cell & Gene Therapy
About
jCyte is pursuing multiple drug development programs for a range of degenerative retinal disorders and optic nerve conditions, focusing on preserving and restoring vision in patients.
Funding History
3Total raised: $109.8M
Series C$64.5MSoleus CapitalAug 15, 2022
Series B$36.8MSanté VenturesDec 15, 2020
Series A$8.5MHatteras Venture PartnersJun 15, 2017
Company Info
TypePrivate
Founded2012
LocationNewport Beach, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile